최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of pharmaceutical investigation, v.49 no.6, 2019년, pp.643 - 654
Al-azzawi, Shafq , Masheta, Dhafir
초록이 없습니다.
Al-Azzawi S (2017) Improving Flurbiprofen brain-permeability and targeting in Alzheimer’s disease by using a novel dendronised ApoE-derived peptide carrier system. (PhD), University of Brighton. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.754004 . Accessed 15 July 2018
Int J Mol Sci S Al-Azzawi 2018 10.3390/ijms19103224 Al-Azzawi S, Masheta D, Guildford AL, Phillips G, Santin M (2018) Dendrimeric poly(epsilon-lysine) delivery systems for the enhanced permeability of flurbiprofen across the blood-brain barrier in Alzheimer’s disease. Int J Mol Sci. https://doi.org/10.3390/ijms19103224
FEBS Lett C Bechara 587 12 1693 2013 10.1016/j.febslet.2013.04.031 Bechara C, Sagan S (2013) Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587(12):1693-1702. https://doi.org/10.1016/j.febslet.2013.04.031
Peptides A Bolhassani 87 50 2017 10.1016/j.peptides.2016.11.011 Bolhassani A, Jafarzade B, Mardani G (2017) In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides. Peptides 87:50-63. https://doi.org/10.1016/j.peptides.2016.11.011
Biomaterials EJ Chung 35 4 1249 2014 10.1016/j.biomaterials.2013.10.064 Chung EJ, Cheng Y, Morshed R, Nord K, Han Y et al (2014) Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 35(4):1249-1256. https://doi.org/10.1016/j.biomaterials.2013.10.064
Dr Discov Today Technol C Cooley 9 1 e49 2012 10.1016/j.ddtec.2011.07.004 Cooley C, Wender P, Geihe E (2012) Beyond cell penetrating peptides: designed molecular transporters. Dr Discov Today Technol 9(1):e49-e55. https://doi.org/10.1016/j.ddtec.2011.07.004
J Pharm Sci AJ D’souza 93 8 1962 2004 10.1002/jps.20096 D’souza AJ, Topp EM (2004) Release from polymeric prodrugs: linkages and their degradation. J Pharm Sci 93(8):1962-1979. https://doi.org/10.1002/jps.20096
Ann Rev Nutr N Diop 2011 10.1146/annurev-nutr-072610-145133 Diop N, Zhao R, Visentin M, Goldman ID (2011) Mechanisms of membrane transport of folates into cells and across epithelia. Ann Rev Nutr. https://doi.org/10.1146/annurev-nutr-072610-145133
J Control Rel S Dissanayake 250 62 2017 10.1016/j.jconrel.2017.02.006 Dissanayake S, Denny WA, Gamage S, Sarojini V (2017) Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J Control Rel 250:62-76. https://doi.org/10.1016/j.jconrel.2017.02.006
Proc Natl Acad Sci A Dubikovskaya 105 34 12128 2008 10.1073/pnas.0805374105 Dubikovskaya A, Thorne H, Pillow H, Contag H, Wender A (2008) Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proc Natl Acad Sci 105(34):12128-12133. https://doi.org/10.1073/pnas.0805374105
Colloids Surf B Biointerfaces N Garg 146 114 2016 10.1016/j.colsurfb.2016.05.051 Garg N, Singh B, Jain A, Nirbhavane P, Sharma R et al (2016) Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B Biointerfaces 146:114-126. https://doi.org/10.1016/j.colsurfb.2016.05.051
Mol Biotechnol A Ghaz 57 3 201 2015 10.1007/s12033-014-9816-3 Ghaz A, Abbaspour F, Anarjan N, Berenjian A, Jafarizadeh H (2015) Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Mol Biotechnol 57(3):201-218. https://doi.org/10.1007/s12033-014-9816-3
Trends Pharmacol Sci G Guidotti 38 4 406 2017 10.1016/j.tips.2017.01.003 Guidotti G, Brambilla L, Rossi D (2017) Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci 38(4):406-424. https://doi.org/10.1016/j.tips.2017.01.003
Scientific Reports Y Guo 6 28983 2016 10.1038/srep28983 Guo Y, Zhao Y, Li R, Wang T, Han M et al (2016) Methotrexate nanoparticles prepared with codendrimer from polyamidoamine (PAMAM) and oligoethylene glycols (OEG) dendrons: antitumor efficacy in vitro and in vivo. Scientific Reports 6:28983. https://doi.org/10.1038/srep28983
Biochim Biophys Acta P Guterstam 1788 12 2509 2009 10.1016/j.bbamem.2009.09.014 Guterstam P, Madani F, Hirose H, Takeuchi T, Futaki S et al (2009) Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Biochim Biophys Acta 1788(12):2509-2517. https://doi.org/10.1016/j.bbamem.2009.09.014
Oncogene J Hutchinson 19 53 6130 2000 10.1038/sj.onc.1203970 Hutchinson J, Muller W (2000) Transgenic mouse models of human breast cancer. Oncogene 19(53):6130-6137. https://doi.org/10.1038/sj.onc.1203970
Bioorg Med Chem V Joncour 26 10 2797 2018 10.1016/j.bmc.2017.08.052 Joncour V, Laakkonen P (2018) Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem 26(10):2797-2806. https://doi.org/10.1016/j.bmc.2017.08.052
Int J Nanomed D Kebebe 13 1425 2018 10.2147/ijn.s156616 Kebebe D, Liu Y, Wu Y, Vilakhamxay M, Liu Z et al (2018) Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers. Int J Nanomed 13:1425-1442. https://doi.org/10.2147/ijn.s156616
Pharmaceuticals V Kersemans 3 3 600 2010 10.3390/ph3030600 Kersemans V, Cornelissen B (2010) Targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy. Pharmaceuticals 3(3):600-620. https://doi.org/10.3390/ph3030600
J Am Chem Soc H Lee 130 29 9364 2008 10.1021/ja710798b Lee H, Dubikovskaya E, Hwang H, Semyonov A, Wang H et al (2008) Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells. J Am Chem Soc 130(29):9364-9370. https://doi.org/10.1021/ja710798b
Biochem Pharmacol M Lindgren 71 4 416 2006 10.1016/j.bcp.2005.10.048 Lindgren M, Rosenthal-Aizman K, Saar K, Eiriksdottir E, Jiang Y et al (2006) Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol 71(4):416-425. https://doi.org/10.1016/j.bcp.2005.10.048
Yao Xue Xue Bao DX Ma 45 9 1165 2010 Ma DX, Qi XR (2010) Comparison of mechanisms and cellular uptake of cell-penetrating peptide on different cell lines. Yao Xue Xue Bao 45(9):1165-1169
J Biophys F Madani 2011 10.1155/2011/414729 Madani F, Lindberg S, Langel L et al (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys. https://doi.org/10.1155/2011/414729
Int J Pept Res Ther M Mäe 15 11 11 2009 10.1007/s10989-008-9156-x Mäe M, Myrberg H, El-Andaloussi S (2009) Design of a tumor homing cell-penetrating peptide for drug delivery. Int J Pept Res Ther 15(11):11
Macromol Biosci S Meikle 11 12 1761 2011 10.1002/mabi.201100267 Meikle S, Perugini V, Guildford AL, Santin M (2011) Synthesis, characterisation and in vitro anti-angiogenic potential of dendron VEGF blockers. Macromol Biosci 11(12):1761-1765. https://doi.org/10.1002/mabi.201100267
Science RB Merrifield 150 3693 178 1965 10.1126/science.150.3693.178 Merrifield RB (1965) Automated synthesis of peptides. Science 150(3693):178-185. https://doi.org/10.1126/science.150.3693.178
J Immunol Methods T Mosmann 65 1-2 55 1983 10.1016/0022-1759(83)90303-4 Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55-63
Bioconjug Chem H Myrberg 19 1 70 2008 10.1021/bc0701139 Myrberg H, Zhang L, Mae M, Langel U (2008) Design of a tumor-homing cell-penetrating peptide. Bioconjug Chem 19(1):70-75. https://doi.org/10.1021/bc0701139
Curr Opin Pharmacol M Najlah 6 5 522 2006 10.1016/j.coph.2006.05.004 Najlah M, D’emanuele A (2006) Crossing cellular barriers using dendrimer nanotechnologies. Curr Opin Pharmacol 6(5):522-527. https://doi.org/10.1016/j.coph.2006.05.004
J G Virol J Park 83 5 1173 2002 10.1099/0022-1317-83-5-1173 Park J, Ryu J, Kim K, Lee H, Bahn J et al (2002) Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J G Virol 83(5):1173-1181. https://doi.org/10.1099/0022-1317-83-5-1173
Eur J Pharm Biopharm E Perez 93 52 2015 10.1016/j.ejpb.2015.03.018 Perez E, Fernandez A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52-79. https://doi.org/10.1016/j.ejpb.2015.03.018
Proc Natl Acad Sci USA J Pilch 103 8 2800 2006 10.1073/pnas.0511219103 Pilch J, Brown D, Komatsu M, Järvinen T, Yang M et al (2006) Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci USA 103(8):2800-2804. https://doi.org/10.1073/pnas.0511219103
Pharmacol Ther D Ramsey 154 78 2015 10.1016/j.pharmthera.2015.07.003 Ramsey D, Flynn H (2015) Cell-penetrating peptides transport therapeutics into cells. Pharmacol Ther 154:78-86. https://doi.org/10.1016/j.pharmthera.2015.07.003
Trends Mol Med D Raucher 21 9 560 2015 10.1016/j.molmed.2015.06.005 Raucher D, Ryu J (2015) Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med 21(9):560-570. https://doi.org/10.1016/j.molmed.2015.06.005
Pharmaceuticals (Basel) J Regberg 5 9 991 2012 10.3390/ph5090991 Regberg J, Srimanee A, Langel U (2012) Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. Pharmaceuticals (Basel) 5(9):991-1007. https://doi.org/10.3390/ph5090991
J Biol Chem JP Richard 280 15 15300 2005 10.1074/jbc.M401604200 Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B et al (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280(15):15300-15306. https://doi.org/10.1074/jbc.M401604200
J Pep Sci H Rodríguez 16 3 136 2010 10.1002/psc.1209 Rodríguez H, Suarez M, Albericio F (2010) A convenient microwave-enhanced solid-phase synthesis of short chain N-methyl-rich peptides. J Pep Sci 16(3):136-140. https://doi.org/10.1002/psc.1209 doi
Adv Drug Deliv Rev E Ruoslahti 110-111 3 2017 10.1016/j.addr.2016.03.008 Ruoslahti E (2017) Tumor penetrating peptides for improved drug delivery. Adv Drug Deliv Rev 110-111:3-12. https://doi.org/10.1016/j.addr.2016.03.008
J Biomed Mater Res A M Shin 102 2 575 2014 10.1002/jbm.a.34859 Shin M, Zhang J, Min K, Lee K, Byun Y et al (2014) Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A 102(2):575-587. https://doi.org/10.1002/jbm.a.34859
R Silverman 2014 The organic chemistry of drug design and drug action 3 Silverman R, Holladay M (2014) The organic chemistry of drug design and drug action, 3rd ed. Elsevier, Oxford
Proc Natl Acad Sci USA D Simberg 104 3 932 2007 10.1073/pnas.0610298104 Simberg D, Duza T, Park JH, Essler M, Pilch J et al (2007) Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA 104(3):932-936. https://doi.org/10.1073/pnas.0610298104
Org Biomol Chem M Soler 13 5 1470 2015 10.1039/c4ob01875c Soler M, Gonzalez-Bartulos M, Figueras E, Ribas X, Costas M et al (2015) Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16. Org Biomol Chem 13(5):1470-1480. https://doi.org/10.1039/c4ob01875c
Org Biomol Chem D Soriano 12 10 1652 2014 10.1039/C3OB42422G Soriano D, Soler M, González-Bártulos M, Ribas X, Costas M et al (2014) Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties. Org Biomol Chem 12(10):1652-1663. https://doi.org/10.1039/C3OB42422G
Acc Chem Res E Stanzl 46 12 2944 2013 10.1021/ar4000554 Stanzl E, Trantow B, Vargas J, Wender P (2013) Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res 46(12):2944-2954. https://doi.org/10.1021/ar4000554
Proc Natl Acad Sci USA V Torchilin 100 4 1972 2003 10.1073/pnas.0435906100 Torchilin V, Levchenko T, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B et al (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 100(4):1972-1977. https://doi.org/10.1073/pnas.0435906100
Mol Pharm JR Vargas 11 8 2553 2014 10.1021/mp500161z Vargas JR, Stanzl EG, Teng NN, Wender PA (2014) Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance. Mol Pharm 11(8):2553-2565. https://doi.org/10.1021/mp500161z
J Biol Chem E Vives 272 25 16010 1997 10.1074/jbc.272.25.16010 Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272(25):16010-16017
Proc Natl Acad Sci USA P Wender 97 24 13003 2000 10.1073/pnas.97.24.13003 Wender P, Mitchell D, Pattabiraman K, Pelkey E, Steinman L et al (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 97(24):13003-13008. https://doi.org/10.1073/pnas.97.24.13003
WHO (2018) Cancer report. http://www.who.int/mediacentre/factsheets/fs297/en . Accessed 2 Oct 2018
ACS Chem Neurosci L Xu 5 1 2 2014 10.1021/cn400182z Xu L, Zhang H, Wu Y (2014) Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci 5(1):2-13. https://doi.org/10.1021/cn400182z
Anti Cancer Agent N Zhao 18 1 74 2018 10.2174/1871520617666170419143459 Zhao N, Qin Y, Liu H, Cheng Z (2018) Tumor-targeting peptides: ligands for molecular imaging and therapy. Anti-cancer agents in medicinal chemistry-. Anti Cancer Agent 18(1):74-86. https://doi.org/10.2174/1871520617666170419143459
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.